Q4 2024 · 13F-HR
FCPM III SERVICES B.V.holdings as filed
Filed 2025-02-14 · accession 0000950123-25-002356
$592.4M
Reported value
8
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $272.3M | 46.0% | 10,597,181 | Common | SHARED |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $128.7M | 21.7% | 5,462,846 | Common | SHARED |
| 29286M105 | — | ENGENE HOLDINGS INC | $64.1M | 10.8% | 9,632,561 | Common | SHARED |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $48.3M | 8.16% | 3,452,330 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $48.1M | 8.12% | 3,970,668 | Common | SHARED |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $25.7M | 4.34% | 2,872,537 | Common | SHARED |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $2.7M | 0.46% | 2,390,050 | Common | SHARED |
| 29286M113 | — | ENGENE HOLDINGS INC | $2.4M | 0.41% | 2,878,148 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.